Welcome To Avidity Avidity is constantly developing new products, providing new tools for the scientific community. we always put the scientific progress first and are open to collaborations with academic and for profit institutes. We are avidity science®. we partner with research facilities around the globe by providing innovative water purification and delivery systems and environmental monitoring and control solutions that reduce research variables, enhance efficiency, and enable science to improve the quality of life.
Welcome To Avidity At avidity biosciences, we are driven by our mission: to profoundly improve people’s lives by revolutionizing a new class of targeted rna therapeutics. we are doing this by realizing the broad and disruptive potential of our antibody oligonucleotide conjugates (aoc™) platform. “avidity’s muscle directed aoc platform and late stage programs advance our rna therapeutics and have the potential to deliver first in disease therapies. with the close of the acquisition, we’re excited to welcome avidity to novartis and accelerate this next generation of medicines.”. Built on the mastery standards defined by international recognition and refined through avidity’s proprietary applied regenerative leadership (arl) ecosystem, we equip organizations to evolve beyond transformation and into regeneration. At avidity, we're dedicated to your success. with our experienced team, including hands on cofounders and seasoned project directors, we ensure meticulous attention to detail and comprehensive design reviews.
Home Welcome To Avidity International Built on the mastery standards defined by international recognition and refined through avidity’s proprietary applied regenerative leadership (arl) ecosystem, we equip organizations to evolve beyond transformation and into regeneration. At avidity, we're dedicated to your success. with our experienced team, including hands on cofounders and seasoned project directors, we ensure meticulous attention to detail and comprehensive design reviews. The acquisition by novartis of avidity is subject to the completion of a spin off or a sale of spinco and other customary closing conditions, including the receipt of regulatory approvals and the approval of avidity stockholders. the companies expect the merger to close in the first half of 2026. Avidity provides purified proteins that have either a biotinylated avitag or a linked to streptavidin for biotin interaction. our protein portfolio contains luciferases and fluorescent proteins that can for example be used for streptavidin biotin quantification. Our vision is to profoundly improve people’s lives by revolutionizing the delivery of rna therapeutics. Avidity service plans with scheduled inspections, calibrations, and maintenance to keep your systems operating at maximum efficiency. click to learn more.
Comments are closed.